Incorporation of acetyl-CoA generated from peroxisomal beta-oxidation into ethanolamine plasmalogen of rat liver.
We have reported that peroxisomal beta-oxidation has an anabolic function, supplying acetyl-CoA for biosyntheses of bile acids and phospholipids. Here we deal with its role in the biosynthesis of the subclasses of ethanolamine- and choline-containing phosphoglycerides (EPG, CPG, respectively). Rats were fed for 2 weeks on chow containing 0.25% clofibrate, which inhibits cholesterol and bile acid biosyntheses, but stimulates peroxisomal beta-oxidation. [1-14C]Lignoceric acid, which is exclusively degraded by peroxisomal beta-oxidation to acetyl-CoA, was intravenously injected, and 3 h later the rats were killed. The EPG-rich and CPG-rich fractions were prepared from the liver. When they were treated with phospholipase A2, the radioactivity was predominantly recovered in the 1-radyl group. The radioactivity in EPG was easily dissociated with HCl vapor, and the lipid containing radioactivity was found to be a fatty aldehyde mixture consisting of steary aldehyde (approx. 58%) palmityl aldehyde (approx. 40%) and oleyl aldehyde (approx. 2%). Thus, in the case of EPG, acetyl-CoA from peroxisomal beta-oxidation is incorporated mainly into the 1-alkenyl group of ethanolamine plasmalogen. The radioactivity in CPG, however, was found in fatty alcohol (formed from fatty acid), but not in alkylglycerol after reduction of the fraction with Vitride. Thus, in the case of CPG, acetyl-CoA from peroxisomal beta-oxidation is exclusively incorporated into the 1-acyl group of diacyl glycerophosphocholine, but not into the 1-alkyl group. The above results were supported by the results of phospholipase C treatment. The above data indicate that peroxisomal beta-oxidation plays a role in supplying acetyl-CoA for 1-alkenyl group of plasmalogen-type phospholipid, but this channel may open only to synthesis of EPG, and almost not to CPG.
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Josai University, Saitama, Japan.
H
H
Hayashi
M
M
Oohashi
D000102:Acetyl-CoA C-Acyltransferase / Q000378:metabolism*; D000818:Animals; D002250:Carbon Radioisotopes; D004983:Ethanolamines / Q000378:metabolism; D005227:Fatty Acids / Q000008:administration & dosage; D005994:Glycerophosphates / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008297:Male; D008830:Microbodies / Q000378:metabolism; D010084:Oxidation-Reduction; D010741:Phospholipases A; D054467:Phospholipases A2; D010955:Plasmalogens / Q000737:chemistry / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D002250:Carbon Radioisotopes; D004983:Ethanolamines; D005227:Fatty Acids; D005994:Glycerophosphates; D010955:Plasmalogens; C020791:phosphatidal ethanolamines; D000102:Acetyl-CoA C-Acyltransferase; D010741:Phospholipases A; D054467:Phospholipases A2; C010210:lignoceric acid